Hematologic Malignancy Clinical Trials in Atlanta, Georgia

3 studies are recruiting for hematologic malignancy in Atlanta, Georgia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

    The safety, tolerability, and antileukemic response of ziftomenib in combination with standard of care treatments for patients with relapsed/refractory acute myeloid leukemia will be examined with the following agents: FLAG-IDA, low-dose cytarabine, and gilteritinib.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Emory Healthcare - The Emory Clinic, Atlanta, Georgia
    Locations
    45 in total
    Run by
    Kura Oncology, Inc.

    See if you can join NCT06001788 on ClinicalTrials.gov

  2. Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation

    This trial will evaluate the safety and efficacy of RIC HIDT transplant protocol following fludarabine and intermediate-dose TBI 800 cGy utilizing PBSC as the stem cell source.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Caitlin Guzowski, Atlanta, Georgia
    Run by
    Northside Hospital, Inc.

    See if you can join NCT05417971 on ClinicalTrials.gov

  3. Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

    Tagraxofusp is a protein-drug conjugate consisting of a diphtheria toxin redirected to target CD123 has been approved for treatment in pediatric and adult patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). This trial aims to examine the safety of this novel agent in pediatric patie…

    Stage
    Phase 1
    Ages
    1 to 21
    Site
    Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia
    Locations
    31 in total
    Run by
    Therapeutic Advances in Childhood Leukemia Consortium

    See if you can join NCT05476770 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.